BILL ANALYSIS

HR7004

BEARISH

Public Integrity in Financial Prediction Markets Act of 2026

HR7004 (Public Integrity in Financial Prediction Markets Act of 2026) has been assessed with a bearish outlook for investors. The primary sectors impacted are Finance. View the full bill text on Congress.gov.

bearish

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR7004 is an early-stage bill with 45 Democratic cosponsors in a Republican-controlled House — very low passage probability.

Even if enacted, the bill restricts only federal employee trading in prediction markets, a niche product line for CME Group.

$CME shows no price reaction to this bill; its event contract business is immaterial to overall revenue.

How HR7004 Affects the Market

Near-zero market impact. $CME trades at $287.01, down 2.82% over the last 30 days, a move consistent with broader equity market trends, not this specific legislative risk. The event contract business at CME is negligible relative to the company's core derivatives franchise. For retail investors, this bill is noise. No actionable trade signal exists from this legislation at its current stage. If the bill somehow advanced (bipartisan support or added to a must-pass package), it could create a small headwind for prediction market volumes, but the probability is too low to factor into valuations.

Bill Details

Metric	Value
Bill Number	HR7004
Market Sentiment	bearish
Event Date	January 9, 2026
Affected Sectors	Finance
Source	View on Congress.gov →

Summary

HR7004 prohibits federal officials from trading prediction market contracts, directly reducing the potential user base for platforms like CME Group's event contract market. The bill is in early legislative stages (referred to committee), with no near-term market impact. $CME trades at $287.01, down 2.82% in the last 30 days, with the event contract business representing a negligible portion of revenue.

Full AI Market Analysis

The 'Public Integrity in Financial Prediction Markets Act of 2026' (HR7004) was introduced on January 9, 2026, by Rep. Ritchie Torres (D-NY) with 45 cosponsors, all Democrats. The bill is in the earliest legislative stage — referred to the Committee on Oversight and Government Reform and the Committee on House Administration. The bill prohibits federal elected officials, congressional employees, political appointees, and executive agency employees from trading prediction market contracts if they possess material nonpublic information. This directly restricts a segment of the potential user base for prediction market platforms. There is no authorized funding in this bill — it is a prohibitory regulatory measure, not a spending bill. The legislative path requires committee hearings, markup, House floor vote, Senate passage, and presidential action. With only Democratic cosponsors in a divided 119th Congress (Republican House majority), passage probability is extremely low in its current form. The bill has had zero actions since its introduction referral, indicating stalled momentum. The primary affected company is CME Group ($CME), which launched CFTC-regulated event contracts in 2024. However, CME's event contract business is a tiny fraction of its total revenue (the company generated ~$6.1B in 2025 revenue from futures/options on interest rates, equities, FX, and commodities). Even if fully enacted, the revenue impact on CME would be negligible, as prediction market contracts are a small product line and federal employees represent a small subset of potential participants. Real market data shows $CME at $287.01 as of April 30, 2026, within its 52-week range of $257.17–$329.16. The stock is down 2.82% over the last 30 days, reflecting broader market conditions rather than this specific bill. The 7-day change of +0.68% shows mild recent recovery. No market reaction to this bill is observable in price data.